Ectodomain shedding of the cell adhesion molecule Nectin-4 in ovarian cancer is mediated by ADAM10 and ADAM17
出版年份 2017 全文链接
标题
Ectodomain shedding of the cell adhesion molecule Nectin-4 in ovarian cancer is mediated by ADAM10 and ADAM17
作者
关键词
-
出版物
JOURNAL OF BIOLOGICAL CHEMISTRY
Volume 292, Issue 15, Pages 6339-6351
出版商
American Society for Biochemistry & Molecular Biology (ASBMB)
发表日期
2017-02-24
DOI
10.1074/jbc.m116.746859
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- The ADAMs family of proteases as targets for the treatment of cancer
- (2016) Maeve Mullooly et al. CANCER BIOLOGY & THERAPY
- Enfortumab Vedotin Antibody-Drug Conjugate Targeting Nectin-4 Is a Highly Potent Therapeutic Agent in Multiple Preclinical Cancer Models
- (2016) P. M. Challita-Eid et al. CANCER RESEARCH
- A proteomic signature of ovarian cancer tumor fluid identified by highthroughput and verified by targeted proteomics
- (2016) Aline Poersch et al. Journal of Proteomics
- Divergent modes of clonal spread and intraperitoneal mixing in high-grade serous ovarian cancer
- (2016) Andrew McPherson et al. NATURE GENETICS
- Control of ADAM17 activity by regulation of its cellular localisation
- (2016) Inken Lorenzen et al. Scientific Reports
- ADAM10: a new player in breast cancer progression?
- (2015) Maeve Mullooly et al. BRITISH JOURNAL OF CANCER
- Cancer statistics, 2015
- (2015) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- It's Totally Tubular...Riding The New Wave of Ovarian Cancer Research
- (2015) R. Perets et al. CANCER RESEARCH
- Nectin-4 expression contributes to tumor proliferation, angiogenesis and patient prognosis in human pancreatic cancer
- (2015) Satoshi Nishiwada et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Diagnostic value of plasma lysophosphatidic acid levels in ovarian cancer patients: A case-control study and updated meta-analysis
- (2015) Liyan Cao et al. JOURNAL OF OBSTETRICS AND GYNAECOLOGY RESEARCH
- Identification of an ADAM17 Cleavage Region in Human CD16 (FcγRIII) and the Engineering of a Non-Cleavable Version of the Receptor in NK Cells
- (2015) Yawu Jing et al. PLoS One
- The diagnostic efficacy of nectin 4 expression in ovarian cancer patients
- (2014) Enas Samir Nabih et al. BIOMARKERS
- Leukocytes require ADAM10 but not ADAM17 for their migration and inflammatory recruitment into the alveolar space
- (2014) J. Pruessmeyer et al. BLOOD
- Hematogenous Metastasis of Ovarian Cancer: Rethinking Mode of Spread
- (2014) Sunila Pradeep et al. CANCER CELL
- Ovarian cancer ascites enhance the migration of patient-derived peritoneal mesothelial cellsviacMet pathway through HGF-dependent and -independent mechanisms
- (2014) Isabelle Matte et al. INTERNATIONAL JOURNAL OF CANCER
- Regulation of CXCR2 expression and function by a disintegrin and metalloprotease-17 (ADAM17)
- (2014) Hemant K. Mishra et al. JOURNAL OF LEUKOCYTE BIOLOGY
- Membranous Nectin-4 expression is a risk factor for distant relapse of T1-T2, N0 luminal-A early breast cancer
- (2014) R Lattanzio et al. Oncogenesis
- Targeting EGFR and PI3K pathways in ovarian cancer
- (2013) S Glaysher et al. BRITISH JOURNAL OF CANCER
- Integrative Analysis of Complex Cancer Genomics and Clinical Profiles Using the cBioPortal
- (2013) J. Gao et al. Science Signaling
- A role for PVRL4-driven cell–cell interactions in tumorigenesis
- (2013) Natalya N Pavlova et al. eLife
- ADAM17 cleaves CD16b (FcγRIIIb) in human neutrophils
- (2012) Yue Wang et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH
- Implementing an online tool for genome-wide validation of survival-associated biomarkers in ovarian-cancer using microarray data from 1287 patients
- (2012) Balázs Győrffy et al. ENDOCRINE-RELATED CANCER
- NIH Image to ImageJ: 25 years of image analysis
- (2012) Caroline A Schneider et al. NATURE METHODS
- siRNA knockdown of ADAM-10, but not ADAM-17, significantly reduces fractalkine shedding following pro-inflammatory cytokine treatment in a human adult brain endothelial cell line
- (2012) Louise A. Hurst et al. NEUROSCIENCE LETTERS
- The cBio Cancer Genomics Portal: An Open Platform for Exploring Multidimensional Cancer Genomics Data: Figure 1.
- (2012) Ethan Cerami et al. Cancer Discovery
- Cooperative Role of Nectin-Nectin and Nectin-Afadin Interactions in Formation of Nectin-based Cell-Cell Adhesion
- (2011) Souichi Kurita et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Different Signaling Pathways Stimulate a Disintegrin and Metalloprotease-17 (ADAM17) in Neutrophils during Apoptosis and Activation
- (2011) Yue Wang et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Integrated genomic analyses of ovarian carcinoma
- (2011) D. Bell et al. NATURE
- TACE/ADAM-17 Phosphorylation by PKC-Epsilon Mediates Premalignant Changes in Tobacco Smoke-Exposed Lung Cells
- (2011) Hassan Lemjabbar-Alaoui et al. PLoS One
- Cross-domain inhibition of TACE ectodomain
- (2011) C. J. Tape et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Nectin 4 Overexpression in Ovarian Cancer Tissues and Serum
- (2010) Melissa S. DeRycke et al. AMERICAN JOURNAL OF CLINICAL PATHOLOGY
- ADAM17 is regulated by a rapid and reversible mechanism that controls access to its catalytic site
- (2010) S. M. Le Gall et al. JOURNAL OF CELL SCIENCE
- Identification of Nectin-4 Oncoprotein as a Diagnostic and Therapeutic Target for Lung Cancer
- (2009) A. Takano et al. CANCER RESEARCH
- Regulation of Mature ADAM17 by Redox Agents for L-Selectin Shedding
- (2009) Y. Wang et al. JOURNAL OF IMMUNOLOGY
- ADAMs 10 and 17 Represent Differentially Regulated Components of a General Shedding Machinery for Membrane Proteins Such as Transforming Growth Factor α, L-Selectin, and Tumor Necrosis Factor α
- (2009) Sylvain M. Le Gall et al. MOLECULAR BIOLOGY OF THE CELL
- ADAM-17 predicts adverse outcome in patients with breast cancer
- (2008) P. M. McGowan et al. ANNALS OF ONCOLOGY
- Specific targeting of metzincin family members with small-molecule inhibitors: Progress toward a multifarious challenge
- (2008) Dimitris Georgiadis et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Potent, exceptionally selective, orally bioavailable inhibitors of TNF-α Converting Enzyme (TACE): Novel 2-substituted-1H-benzo[d]imidazol-1-yl)methyl)benzamide P1′ substituents
- (2008) Gregory R. Ott et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- New therapies for ovarian cancer: Cytotoxics and molecularly targeted agents
- (2008) Phuong Dinh et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now